Cable Hill Partners »

Regeneron Pharmaceuticals shares owned by Cable Hill Partners

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Cable Hill Partners from 13F filings

Historical chart of Cable Hill Partners investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Cable Hill Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Cable Hill Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $427k 406 1051.24
2024-06-30 $431k 410 1051.03
2023-09-30 $402k 489 822.96
2023-06-30 $340k 473 718.54
2023-03-31 $461k 561 821.67
2022-12-31 $391k 542 721.49
2022-09-30 $360k 522 689.66
2022-06-30 $267k 452 590.71
2022-03-31 $300k 430 697.67
2021-12-31 $269k 426 631.46
2021-09-30 $258k 426 605.63
2021-06-30 $235k 420 559.52
2016-09-30 $5.0k 13 384.62